Pulike Biological Engineering Inc
SSE:603566
Pulike Biological Engineering Inc
PP&E Net
Pulike Biological Engineering Inc
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pulike Biological Engineering Inc
SSE:603566
|
PP&E Net
¥1.2B
|
CAGR 3-Years
34%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
PP&E Net
¥3.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
PP&E Net
¥697.2m
|
CAGR 3-Years
20%
|
CAGR 5-Years
23%
|
CAGR 10-Years
9%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
PP&E Net
¥7.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
16%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
PP&E Net
¥4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
PP&E Net
¥2.5B
|
CAGR 3-Years
60%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
Pulike Biological Engineering Inc
Glance View
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
See Also
What is Pulike Biological Engineering Inc's PP&E Net?
PP&E Net
1.2B
CNY
Based on the financial report for Sep 30, 2024, Pulike Biological Engineering Inc's PP&E Net amounts to 1.2B CNY.
What is Pulike Biological Engineering Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
27%
Over the last year, the PP&E Net growth was 13%. The average annual PP&E Net growth rates for Pulike Biological Engineering Inc have been 34% over the past three years , 27% over the past five years .
You don't have any saved screeners yet